MC10 Joins Forces With University of Rochester To Advance Patient-Centered Research
CAMBRIDGE, Mass. & ROCHESTER, N.Y.--(BUSINESS WIRE)--MC10, Inc., the pioneer in biometric sensor enabled clinically insightful analytics, announced a collaboration with University of Rochester, a leading academic research institution. This initiative unites MC10’s powerful technological capabilities in physiological sensing and pattern recognition algorithms with the University of Rochester’s clinical expertise and commitment to big data analytics to drive solutions for today’s most pressing healthcare challenges.
“Connected health technologies hold the potential to disrupt the way we monitor the progression of neurodegenerative disorders today and to assess the response to novel therapeutics”
University of Rochester’s Hajim School of Engineering and Applied Sciences will lead the effort. Robert Clark, Dean of the School of the Hajim School of Engineering and Applied Sciences, sees the collaboration with MC10 as supportive of the university’s efforts to translate patient healthcare data into actionable findings.
“At University of Rochester, we are committed to fostering collaborative research to improve human health,” Dean Clark said. “We see great potential in working with MC10 and in exploiting the biometric insights that are realized from MC10’s technology platform in addressing some of the greatest challenges we see in healthcare today.”
MC10 sought out a collaboration with the University of Rochester based on its world-class facilities and its vision to be the 21st century leader in data science. The university’s efforts in this field include a commitment of $100 million to the creation of the Georgen Institute for Data Science, a center focused on using healthcare data and leading edge data analytics to advance medicine.
MC10 is uniquely positioned to support the university in its research efforts with its BioStamp™ platform which consists of MC10’s novel biometric sensing devices, a companion software application, and an end-to-end cloud storage and computing platform. BioStamp™ will be put to the test in a variety of clinical settings by a diverse group of researchers at the University of Rochester, which will further drive MC10’s collection of big data and development of disease-specific algorithms for use in predictive health analytics. MC10 will maximize its engineering support for this collaboration by opening an office in Rochester, NY and it also intends to collaborate with graduate students from the Hajim School of Engineering and Applied Sciences.
Additionally, University of Rochester Medical Center’s Dr. Ray Dorsey, Professor of Neurology and Director of CHET, will lead research efforts in the field of neurodegenerative disease.
“Connected health technologies hold the potential to disrupt the way we monitor the progression of neurodegenerative disorders today and to assess the response to novel therapeutics,” said Dr. Dorsey. “Wearable sensors, like those from MC10, can enable objective, sensitive, frequent assessments of an individual’s condition to improve their health and advance new treatments for neurological conditions. Through the seamless exchange of data between patients and physicians we can move healthcare outside of the clinic and truly overcome distance and disability.”
MC10’s CEO Scott Pomerantz, a University of Rochester alumnus and member of the Dean’s Advisory Council (DAC), will join Dr. Dorsey at University of Rochester’s d.health Summit on Friday, May 29th to share MC10’s healthcare vision and to discuss mobile medicine. The Summit brings together healthcare leaders, entrepreneurs, policymakers, and forward thinkers to foster disruptive solutions to improve the health of aging Americans.
“At MC10 we believe that technologies to enable better clinical decision making are instrumental for improving American health, said Mr. Pomerantz. “We are building the team, technology and partnerships to be better positioned than ever to have a transformational impact on healthcare.”
MC10 brings healthcare into the home with products that unite consumer design with clinical-grade sensing and insight. The company develops body onboard diagnostics systems that can collect human physiological data from any body location to deliver actionable health insights. MC10 is headquartered in Cambridge, MA. Visit MC10 online at www.mc10inc.com.
BioStamp™, MC10 and the MC10 logo are registered marks owned by MC10, Inc.
About University of Rochester:
The University of Rochester (www.rochester.edu) is one of the nation’s leading private universities. Located in Rochester, N.Y., the University gives students exceptional opportunities for interdisciplinary study and close collaboration with faculty through its unique cluster-based curriculum. Its College, School of Arts and Sciences, and Hajim School of Engineering and Applied Sciences are complemented by its Eastman School of Music, Simon School of Business, Warner School of Education, Laboratory for Laser Energetics, School of Medicine and Dentistry, School of Nursing, Eastman Institute for Oral Health, and the Memorial Art Gallery.